Source | Match | ReputationScore* |
---|---|---|
CASPS: A Phase II trial of Cediranib in ASPS patients
Collection of samples and data across the following diseases: Malignant neoplasm of connective tissue (disorder) CASPS is a two-arm, randomised, double-blind, placebo-controlled, Phase II trial of cediranib in ASPS patients. The primary objective is
...
|
|
*ReputationScore indicates how established a given datasource is. Find out more.